12-2668924-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000719.7(CACNA1C):​c.4624-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000277 in 1,604,908 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0015 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 1 hom. )

Consequence

CACNA1C
NM_000719.7 intron

Scores

2
Splicing: ADA: 0.001406
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.273
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C-AS2 (HGNC:40118): (CACNA1C antisense RNA 2)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 12-2668924-C-T is Benign according to our data. Variant chr12-2668924-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 136627.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-2668924-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00149 (227/152330) while in subpopulation AFR AF= 0.00522 (217/41578). AF 95% confidence interval is 0.00465. There are 1 homozygotes in gnomad4. There are 100 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 227 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.4624-9C>T intron_variant Intron 37 of 46 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.4624-9C>T intron_variant Intron 37 of 46 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.4624-9C>T intron_variant Intron 37 of 46 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.4624-9C>T intron_variant Intron 37 of 46 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.4858-9C>T intron_variant Intron 39 of 49 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.4624-9C>T intron_variant Intron 37 of 47 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.4591-9C>T intron_variant Intron 36 of 46 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.4789-9C>T intron_variant Intron 38 of 47 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.4768-9C>T intron_variant Intron 39 of 48 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.4690-9C>T intron_variant Intron 37 of 46 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.4624-9C>T intron_variant Intron 37 of 47 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.4624-9C>T intron_variant Intron 37 of 47 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.4714-9C>T intron_variant Intron 37 of 46 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.4714-9C>T intron_variant Intron 37 of 46 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.4714-9C>T intron_variant Intron 37 of 46 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.4714-9C>T intron_variant Intron 37 of 46 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.4708-9C>T intron_variant Intron 38 of 47 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.4699-9C>T intron_variant Intron 38 of 47 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.4684-9C>T intron_variant Intron 38 of 47 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.4624-9C>T intron_variant Intron 37 of 46 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.4624-9C>T intron_variant Intron 37 of 46 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.4624-9C>T intron_variant Intron 37 of 46 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.4675-9C>T intron_variant Intron 37 of 46 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.4666-9C>T intron_variant Intron 37 of 46 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.4591-9C>T intron_variant Intron 36 of 45 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.4591-9C>T intron_variant Intron 36 of 45 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.4585-9C>T intron_variant Intron 36 of 45 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.4624-9C>T intron_variant Intron 37 of 46 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.4624-9C>T intron_variant Intron 37 of 46 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.4624-9C>T intron_variant Intron 37 of 46 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.4624-9C>T intron_variant Intron 37 of 46 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.4624-9C>T intron_variant Intron 37 of 46 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.4615-9C>T intron_variant Intron 37 of 46 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.4591-9C>T intron_variant Intron 36 of 45 ENSP00000507309.1 Q13936-19

Frequencies

GnomAD3 genomes
AF:
0.00148
AC:
226
AN:
152212
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00521
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000957
GnomAD3 exomes
AF:
0.000364
AC:
91
AN:
250094
Hom.:
1
AF XY:
0.000310
AC XY:
42
AN XY:
135510
show subpopulations
Gnomad AFR exome
AF:
0.00503
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000219
Gnomad SAS exome
AF:
0.0000654
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000883
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000150
AC:
218
AN:
1452578
Hom.:
1
Cov.:
28
AF XY:
0.000127
AC XY:
92
AN XY:
723344
show subpopulations
Gnomad4 AFR exome
AF:
0.00499
Gnomad4 AMR exome
AF:
0.000201
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000177
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000163
Gnomad4 OTH exome
AF:
0.000266
GnomAD4 genome
AF:
0.00149
AC:
227
AN:
152330
Hom.:
1
Cov.:
32
AF XY:
0.00134
AC XY:
100
AN XY:
74486
show subpopulations
Gnomad4 AFR
AF:
0.00522
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000578
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000947
Alfa
AF:
0.00111
Hom.:
0
Bravo
AF:
0.00143
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 06, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 25, 2013
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Sep 16, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

CACNA1C: BS1 -

Long QT syndrome Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
13
DANN
Benign
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0014
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs377568567; hg19: chr12-2778090; API